Literature DB >> 17004525

Metamizole use among Hispanics in Miami: report of a survey conducted in a primary care setting.

Santiago Garcia1, Mariana Canoniero, Gilberto Lopes, Andrés Omar Soriano.   

Abstract

BACKGROUND: Metamizole (dipyrone) is a myelotoxic, nonsteroidal anti-inflammatory agent that has been banned from the US market since 1979. However, dipyrone may be purchased in some areas of the US. We conducted a survey in a primary care setting in Miami, Florida to determine the prevalence of metamizole possession and use among Hispanics living in this area.
METHODS: Participants consisted of 137 Hispanic outpatients interviewed consecutively during a primary care visit in the month of February 2005.
RESULTS: Metamizole was possessed by 28% of the surveyed population. The most common reasons for using dipyrone were pain (72%) and fever (24%). The vast majority of patients had purchased the medication in Latin America (95%), in most instances without a prescription (95%). Nineteen patients (13%) had used the medication during the previous year.
CONCLUSIONS: Metamizole is available to Latino immigrants who reside in the US, despite the FDA ban imposed in 1977.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17004525     DOI: 10.1097/01.smj.0000233020.68212.8f

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  2 in total

Review 1.  The Pain Experience of Hispanic Americans: A Critical Literature Review and Conceptual Model.

Authors:  Nicole A Hollingshead; Leslie Ashburn-Nardo; Jesse C Stewart; Adam T Hirsh
Journal:  J Pain       Date:  2016-01-30       Impact factor: 5.820

Review 2.  Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review.

Authors:  David W Hein; Lori M Millner
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-11-03       Impact factor: 4.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.